• Rapid Purification of Recombinant Annexin V for Biophysical

  2026-05-30

  Burger et al. developed a rapid, efficient method for purifying recombinant Annexin V, addressing the need for high-purity protein in biophysical analyses of its ion channel activity and phosphatidylserine binding. Their protocol leverages reversible calcium-mediated liposome binding and mild cell lysis, minimizing contamination and streamlining downstream applications in apoptosis and cell death research.

• Optimizing hiPSC-Derived Platelet Production via Small Molec

  2026-05-29

  This study presents a cost-effective, optimized protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs), leveraging increased embryoid body (EB) input, human platelet lysate, and small molecule modulators. The approach significantly accelerates differentiation, improves yield, and reduces cost, with implications for scalable platelet manufacture and translational research.

• OPP in B Cell Research: Illuminating Protein Synthesis and I

  2026-05-29

  Discover how O-propargyl-puromycin (OPP) transforms the measurement of protein synthesis in B cells, bridging mitochondrial dynamics and adaptive immunity. This article synthesizes mechanistic breakthroughs on Pcbp1’s role in mitochondrial integrity with strategic protocol guidance, positioning OPP as a powerful, next-generation proteomics reagent. Includes protocol parameters, competitive landscape, translational relevance, and a forward-looking perspective for researchers.

• MOG (35-55): Mechanistic Frontiers and Translational Leverag

  2026-05-28

  This thought-leadership article explores how the MOG (35-55) myelin oligodendrocyte glycoprotein peptide empowers translational researchers to model complex autoimmune neuroinflammation with mechanistic precision. Integrating recent breakthroughs in interferon signaling and PARP7 inhibition, it offers strategic guidance on optimizing experimental autoimmune encephalomyelitis (EAE) models for multiple sclerosis (MS) research, and positions APExBIO's peptide as a catalyst for next-generation discoveries.

• Dantrolene Sodium Salt: Precision Modulation of RyR Pathways

  2026-05-28

  Explore how Dantrolene sodium salt, a potent ryanodine receptor antagonist, uniquely enables advanced control of calcium signaling and DNA repair pathway choice in genome editing and disease models. This analysis goes beyond standard protocols, highlighting mechanistic insights and translational opportunities.

• BMS-777607: c-Met Inhibitor for Enhanced Platelet and Cancer

  2026-05-27

  BMS-777607 enables precise inhibition of MET signaling, streamlining both cancer metastasis and hiPSC-derived platelet production workflows. Discover how recent protocol advances and troubleshooting insights unlock higher assay reproducibility and cost-effectiveness.

• Meta-Analysis Confirms Azilsartan Medoxomil’s Efficacy in Hy

  2026-05-27

  A 2024 systematic review and meta-analysis evaluated azilsartan medoxomil (TAK 491) for hypertension, revealing superior blood pressure reduction versus control therapies and consistent safety, even in diabetic patients. These findings inform both clinical and preclinical research on angiotensin II receptor signaling and essential hypertension treatment.

• Poria cocos Polysaccharides Mitigate ALD via NRF2-Ferroptosi

  2026-05-26

  This study reveals that Poria cocos polysaccharides (PCP) ameliorate alcoholic liver disease (ALD) by modulating the NRF2 signaling pathway and inhibiting ferroptosis. These findings identify a mechanistic link between NRF2 activation, oxidative stress reduction, and liver protection, suggesting new therapeutic angles for ALD intervention.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In

  2026-05-26

  Wang et al. (2018) provide compelling evidence that genotype III grass carp reovirus (GCRV104) enters host cells via clathrin-mediated, pH-dependent endocytosis, using a systematic pharmacological inhibitor screen. Their findings clarify viral entry mechanisms and highlight key distinctions among endocytic pathways, with direct implications for virology and cell biology assay design.

• USP42 Drives Breast Cancer by Blocking JNK/p38-Mediated Apop

  2026-05-25

  The referenced study identifies USP42 as a key promoter of breast cancer progression, acting via inhibition of the JNK/p38 apoptotic signaling pathway. By integrating molecular, cellular, and in vivo analyses, the research reveals USP42 as a potential therapeutic target for overcoming apoptosis resistance in breast cancer.

• Rosiglitazone (Brl-49653): PPARγ Agonist for Type II Diabete

  2026-05-25

  Rosiglitazone, also known as Brl-49653, is a synthetic thiazolidinedione PPARγ agonist with well-documented utility in type II diabetes research. This agent enhances insulin sensitivity and adipogenesis by modulating PPARγ-driven gene expression, with effects confirmed in both cellular and animal models. Its applications extend to mechanistic dissection of adipocyte biology and the rescue of partial PPARγ loss-of-function mutations.

• Force-Threshold Regulation of Root Resorption via Nrf2/Keap1

  2026-05-24

  This study uncovers how varying magnitudes of orthodontic force modulate root resorption through the Nrf2/Keap1/p62 antioxidant pathway. By defining the force-dependent activation and saturation thresholds of Nrf2, the research identifies a mechanosensitive switch linking oxidative stress, inflammation, and tissue remodeling with implications for therapeutic prevention of root resorption.

• Hematoxylin and Eosin Staining Kit: Technical Guide and QC

  2026-05-23

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) addresses the need for reliable, ready-to-use solutions for tissue morphology visualization in research settings. It is best suited for histopathological and cytological studies using paraffin or frozen tissue sections, but is not intended for diagnostic or medical applications. This guide provides actionable workflow and troubleshooting advice for laboratory scientists.

• BMS-777607: Transforming MET Pathway Research & Platelet Pro

  2026-05-22

  Explore how BMS-777607, a highly selective c-Met inhibitor from APExBIO, is redefining translational research by bridging advanced cancer models and stem cell-derived platelet protocols. This article delivers mechanistic insight, actionable protocol guidance, and strategic vision for researchers leveraging MET signaling pathway inhibition to unlock new frontiers in metastasis suppression and functional platelet generation.

• Balsalazide Disodium: Novel 5-ASA Prodrug in Ulcerative Coli

  2026-05-22

  Wiggins and Rajapakse’s reference study details the unique design and clinical performance of balsalazide disodium—a prodrug engineered to optimize 5-aminosalicylic acid (5-ASA) delivery for ulcerative colitis. Their findings underscore its superior induction of remission and favorable tolerability profile, highlighting its translational relevance for both clinical and preclinical inflammation research.

16356 records 1/1091 page Next 12345 下5页 Last page